← Back to Search

Time Restricted Eating for Obesity

N/A
Waitlist Available
Led By Michael J Wilkinson, MD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
If patients are on cardiovascular medications (HMG CoA reductase inhibitors (statins), other lipid modifying drugs (including over the counter drugs such as red yeast rice and fish oil), anti-hypertensive drugs, no dose adjustments will be allowed during the study period.
BMI 30-50 kg/m2
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 14 weeks
Awards & highlights

Study Summary

This trial will compare the health impact of time-restricted eating in obese patients to standard nutritional counseling.

Who is the study for?
Adults over 18 with obesity (BMI of 30-50), who eat for more than 14 hours a day and own a smartphone. They must not be on any weight-affecting meds, pregnant, or have various health conditions like heart failure or uncontrolled psychiatric disorders. Those on stable cardiovascular meds can join but can't change doses during the trial.Check my eligibility
What is being tested?
The study is testing if limiting eating to a 10-hour window (Time-Restricted Eating) plus nutritional counseling affects obese adults' health differently compared to just nutritional counseling alone. Participants will follow their assigned eating plan for 12 weeks.See study design
What are the potential side effects?
Since this trial involves dietary changes rather than medication, side effects may include hunger outside of the eating window, potential changes in energy levels, mood alterations due to diet change, and possible impact on social life or routine.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am not changing my heart or cholesterol medication doses during the study.
Select...
My BMI is between 30 and 50.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 14 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 14 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effects of TRE on body composition
Effects of TRE on body weight
Effects of TRE on catecholamine sensitivity of obese adipose tissue (Exploratory Outcome)
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: TRE + SOCExperimental Treatment1 Intervention
Participants in this arm will receive standard of care nutritional behavioral counseling and will implement a daily, self-selected, 10-hour window within which they must consume all calories. They will also be required to log their caloric intake through the use of a smartphone app
Group II: Standard of Care (SOC)Placebo Group1 Intervention
Participants will receive standard of care nutritional behavioral counseling and will be required to log their caloric intake through the use of a smartphone app.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Time Restricted Eating
2018
N/A
~50

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,120 Previous Clinical Trials
1,521,346 Total Patients Enrolled
52 Trials studying Obesity
7,421 Patients Enrolled for Obesity
Salk Institute for Biological StudiesOTHER
19 Previous Clinical Trials
1,746 Total Patients Enrolled
3 Trials studying Obesity
364 Patients Enrolled for Obesity
Michael J Wilkinson, MDPrincipal InvestigatorUniversity of California, San Diego

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
Altman Clinical and Translational Research Institute
What portion of applicants met pre-screening criteria?
Met criteria
~11 spots leftby Apr 2025